SCHEMBL29317683

SCHEMBL29317683

CC(C)OC(C)(C)C(=O)NS(=O)(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 7/20 0.59
MITF O75030 2/20 0.47
LARS1 Q9P2J5 1/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PPARG P37231 1/20 0.46
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
CA2 P00918 1/20 0.43
TARS1 P26639 1/20 0.42
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
GAA P10253 1/20 0.42
KDM4E B2RXH2 1/20 0.42
EGFR P00533 1/20 0.42
ERBB2 P04626 1/20 0.42
BCAT1 P54687 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29317764 0.87 PPARA (0.45) PPARALMNASMN1; SMN2CA2TARS1
SCHEMBL29321248 0.85 CA1 (0.48) PPARASMN1; SMN2HTTCA2PTGS1
SCHEMBL29317748 0.84 MMP2 (0.50) PPARALMNASMN1; SMN2CA2EGFR
SCHEMBL29317750 0.84 PPARA (0.43) PPARALMNASMN1; SMN2MAPTGAA
SCHEMBL29317752 0.84 F2 (0.45) PPARALARS1LMNACA2
SCHEMBL29317754 0.84 LARS1 (0.53) PPARALARS1LMNAKMT2ASMN1; SMN2
SCHEMBL29317746 0.83 MMP1 (0.48) PPARACA2
SCHEMBL29321247 0.83 PPARA (0.42) PPARAMITFLMNAHPGDKMT2A
SCHEMBL29321254 0.82 CA1 (0.52) PPARALMNASMN1; SMN2MAPTHTT
SCHEMBL29317687 0.82 MMP13 (0.47) PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145931-A1 SMALL MOLECULE INHIBITOR FOR β-CATENIN/BCL9 PROTEIN-PROTEIN INTERACTION AND USE THEREOF 上海医药工业研究院有限公司 2024-07-11 WO disclosed